Literature DB >> 7498243

Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome.

J P Drenth1, R J Powell, N S Brown, J W Van der Meer.   

Abstract

The hyperimmunoglobulinaemia D and periodic fever (hyper-IgD) syndrome is typified by recurrent unpredictable febrile attacks with abdominal pain, joint involvement (arthralgias/arthritis), headache, skin lesions and a polyclonal elevation of serum IgD (> 100 U mL-1). Interferon-gamma (IFN-gamma) is a major proinflammatory cytokine which could play a role in the pathogenesis of the attacks. There is a need for parameters (if possible non-invasive) to monitor disease activity. A potential candidate is neopterin which is released by monocytes/macrophages when stimulated with IFN-gamma, excreted unchanged in urine, and appears to be an early and sensitive marker for activation of the immune system. We measured rectal body temperature, serum IFN-gamma, and urine neopterin in 10 hyper-IgD patients both during and between attacks. The body temperature rose to a mean of 38.9 degrees C on the first day of the attack and normalized within 5 days. Serum IFN-gamma during the first day of the attack was 2.98 IU mL-1 and was significantly lower during remissions. The urine neopterin excretion was 268 +/- 170 mumol mol-1 creatinine between attacks and was significantly increased to 638 +/- 275 mumol mol-1 creatinine on the first day of symptoms. Maximal urine neopterin values were reached on the fourth day of the attack (1051 +/- 387 mumol mol-1 creatinine) and excretion gradually declined and attained values below 400 mumol mol-1 creatinine after 9 days. There was a good correlation between serum IFN-gamma and urine neopterin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498243     DOI: 10.1111/j.1365-2362.1995.tb01986.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.

Authors:  J P Drenth; J Göertz; M R Daha; J W van der Meer
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

2.  Increased urinary leukotriene E(4) during febrile attacks in the hyperimmunoglobulinaemia D and periodic fever syndrome.

Authors:  J Frenkel; M A Willemsen; C M Weemaes; L Dorland; E Mayatepek
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

3.  Knockdown of MVK does not lead to changes in NALP3 expression or activation.

Authors:  Fulvio Celsi; Elisa Piscianz; Maurizio Romano; Sergio Crovella
Journal:  J Inflamm (Lond)       Date:  2015-01-31       Impact factor: 4.981

4.  30 years hids-Travels between bedside and bench.

Authors:  Jos W M van der Meer
Journal:  Temperature (Austin)       Date:  2015-02-03

Review 5.  Mevalonate kinase deficiency: current perspectives.

Authors:  Leslie A Favier; Grant S Schulert
Journal:  Appl Clin Genet       Date:  2016-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.